Quanex Building Products (NX) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
1 Feb, 2026Executive summary
Q2 2024 net sales were $266.2 million, down 2.7–3% year-over-year, mainly due to softer demand in European Fenestration and North American Cabinet Components.
Net income for Q2 was $15.4 million ($0.46 per diluted share), a 29% decrease from Q2 2023; adjusted net income was $21.8 million ($0.66 per share), flat year-over-year.
The $1.1 billion Tyman acquisition is progressing, expected to close in the second half of 2024, with both boards' approval and regulatory filings complete.
The company entered a $605 million FX forward contract to hedge currency risk for the Tyman deal.
Continued investment in expanding the customer base, product portfolio, and R&D, including new compounds and security screen products.
Financial highlights
Adjusted EBITDA for Q2 was $40 million (15.0% margin), up from $39.9 million (14.6%) in Q2 2023, with consolidated margin expansion of 40 basis points.
Free cash flow for Q2 was $25.5 million, slightly lower year-over-year due to higher CapEx.
Six-month net sales were $505.4 million, down from $535.5 million year-over-year.
Cash and equivalents at April 30, 2024, were $56.1 million, with no borrowings under the $325 million credit facility.
Q2 2024 gross margin was 24.9%, up from 24.6% in Q2 2023.
Outlook and guidance
Fiscal 2024 guidance reaffirmed: consolidated net sales of ~$1.1 billion and adjusted EBITDA of $145–$150 million.
Q3 2024 revenue expected to be up 4–6% sequentially; by segment, North American Fenestration up 6–8%, European Fenestration up 4–6%, and North American Cabinet Components down 1–3%.
Adjusted EBITDA margin expected to be flat to down 25 basis points in Q3 versus Q2.
Free cash flow outlook remains at $85–$90 million for the year, with some impact from transaction and advisory fees.
Guidance excludes any impact from the Tyman acquisition.
Latest events from Quanex Building Products
- Net sales rose 2.3% to $409.1 million, but adjusted EBITDA margin declined to 6.7%.NX
Q1 20266 Mar 2026 - Board recommends voting for all directors, executive pay, and new auditor, with strong governance and ESG focus.NX
Proxy Filing28 Jan 2026 - Q3 results met expectations; Tyman acquisition closed, integration progressing, and FY24 guidance raised.NX
Q3 202421 Jan 2026 - Tyman acquisition drove record sales and margin gains, with a 2025 rebound expected.NX
Q4 202411 Jan 2026 - Q3 sales jumped 77% with Tyman, but a $302.3M goodwill impairment led to a $276M net loss.NX
Q3 202531 Dec 2025 - Targets ~$4B revenue by 2029, leveraging Tyman synergies, innovation, and margin expansion.NX
Investor Day 202529 Dec 2025 - Sales up 67% in Q1, net loss $14.9M, guidance reaffirmed, synergy and margin gains on track.NX
Q1 202526 Dec 2025 - Net sales up 43.8% to $1.84B; Monterrey recovery and strong cash flow drive debt reduction.NX
Q4 202513 Dec 2025 - Shareholders to vote on Quanex’s £788M acquisition of Tyman, with up to 32% ownership for Tyman holders.NX
Proxy Filing1 Dec 2025